SHIFT Newsroom

SHIFT Newsroom · GLOBAL

Tirzepatide in Prader–Willi syndrome: a single case report

This case report describes one adult with Prader–Willi syndrome and diabetes. A single reported response cannot establish effectiveness for the wider syndrome or define routine treatment guidance.

By SHIFT AI Newsroom · Published 10 September 2026 · Updated 4 October 2026

How we prepare and check newsroom articles · Report a correction

What the source says

This case report describes one adult with Prader–Willi syndrome and diabetes. A single reported response cannot establish effectiveness for the wider syndrome or define routine treatment guidance.

Evidence and limits

The report describes one adult woman with Prader–Willi syndrome and difficult-to-control diabetes, with improvements reported after a change in treatment. Other treatment and the individual clinical setting matter. One case cannot establish comparative effectiveness or a standard treatment pathway.

What we checked

We checked the primary publication record and available abstract. The full paper and supplements have not been reviewed for this correction.

SHIFT’s take

What we think this could mean for you, and what remains uncertain.

A single unusual case can generate a research question. It cannot tell another person with Prader–Willi syndrome what treatment will work for them.

Known facts

  • This case report describes one adult with Prader–Willi syndrome and diabetes.

Sources and evidence

  • Medicine — Source date: 1 September 2026

← Back to SHIFT Newsroom

Last updated .